Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus

HIV-1 neutralizing antibodies induced by native-like envelope trimers

(2015) R. W. Sanders et al.   SCIENCE

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera

(2015) Joan O. Ngwuta et al.   Science Translational Medicine

A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism

(2015) Anders Krarup et al.   Nature Communications

Neutralizing epitopes on the respiratory syncytial virus fusion glycoprotein

(2015) Jason S McLellan   Current Opinion in Virology

RSV Vaccine-Enhanced Disease Is Orchestrated by the Combined Actions of Distinct CD4 T Cell Subsets

(2015) Cory J. Knudson et al.   PLoS Pathogens

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein

(2015) Morgan S. A. Gilman et al.   PLoS Pathogens

Effect of Formaldehyde Inactivation on Poliovirus

(2014) T. Wilton et al.   JOURNAL OF VIROLOGY

An Overview of Respiratory Syncytial Virus

(2014) Jia Meng et al.   PLoS Pathogens

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

(2013) J. S. McLellan et al.   SCIENCE

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes

(2011) J. S. McLellan et al.   JOURNAL OF VIROLOGY

A flow cytometry-based assay to assess RSV-specific neutralizing antibody is reproducible, efficient and accurate

(2010) M. Chen et al.   JOURNAL OF IMMUNOLOGICAL METHODS